Screener
Prestige Consumer Healthcare PBH Debt Issuance Proceeds
Debt Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.
The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:15 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001295947-26-000042
| (In thousands) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 |
|---|---|---|
| Deposits for business acquisitions and other | (15,034) | (1,100) |
| Net cash (used in) investing activities | (1,063,737) | (1,938) |
| Financing Activities | ||
| Proceeds from issuance of Term Loan | 1,045,000 | — |
| Net increase in line of credit | 653 | — |
| Payments of debt issuance costs | (22,476) | — |
| Payments of finance leases | (576) | (608) |
| Proceeds from exercise of stock options | — | 3,155 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Prestige Consumer Healthcare's debt issuance proceeds?
- Prestige Consumer Healthcare (PBH) reported debt issuance proceeds of $1.05B in Q2 2026.
- What does debt issuance proceeds mean?
- Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.
Ask your AI about Prestige Consumer Healthcare's debt issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude